Actuate Therapeutics IncACTUNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
2.82%
↓ 83% vs avg
Percentile
P40
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
16.61%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 2.82% |
| Q2 2025 | 1.87% |
| Q1 2025 | 9.47% |
| Q4 2024 | 75.64% |
| Q3 2024 | 53.94% |
| Q2 2024 | 16.41% |
| Q1 2024 | -5.83% |
| Q4 2023 | 35.73% |
| Q3 2023 | -11.52% |
| Q2 2023 | 4.18% |
| Q1 2023 | 0.00% |